Patients living in rural areas of North America may not receive guideline-concordant care because of diminished or accelerated access to surgery and lack of access to the full spectrum of treatment ...
As the curtain closed on 2024, FDA issued a new draft guidance to assist clinical trial sponsors, investigators, and institutional review boards (“IRBs”) with defining, identifying, and reporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results